When discussing hormone replacement therapy (HRT), especially with older patients, a common concern is the perceived risks associated with starting or continuing HRT later in life. This chapter delves into the often-misunderstood topic of HRT in women over 60 and how it can impact heart and brain health. We’ll explore the benefits of HRT, the risks, and why it’s essential to have an informed discussion with your doctor, especially when they might not be fully aware of the latest research.
Estrogen plays a crucial role in maintaining heart and vascular health, but the research on this topic has been complex and sometimes contradictory. The Women’s Health Initiative (WHI), a significant study from the early 2000s, has been particularly influential in shaping the narrative around HRT and heart disease. However, the WHI’s findings have led to confusion, especially since its design included an older population of postmenopausal women (average age of 66), many of whom were far removed from the onset of menopause.
This age factor is critical because it influenced the study’s outcomes. When HRT is started closer to the onset of menopause, the risks associated with heart disease appear to be lower, and in some cases, there may even be a protective effect. For example, data from the WHI, when stratified by age, shows that women aged 50-59 who started estrogen therapy shortly after menopause experienced a protective effect against heart attacks. However, this benefit was neutralized in women aged 60-69 and showed a trend toward increased risk in women aged 70-79.
Several studies have further explored the relationship between HRT and heart health, particularly in younger women or those closer to menopause:
These studies suggest that initiating HRT at the onset of menopause or soon after may protect heart health. This evidence contradicts the long-standing belief that HRT is inherently risky for older women, especially if started after the 10-year mark from menopause.
For women in their 60s and 70s, the decision to start or continue HRT can be more complex. These women often face an increased risk of heart disease due to age-related factors like insulin resistance, high blood pressure, obesity, and inflammation. However, not all older women develop these risk factors, and it’s essential to consider individual health status rather than applying a one-size-fits-all approach.
In cases where older women are healthy and do not exhibit significant cardiovascular risk factors, it may be reasonable to consider HRT, especially if they suffer from osteoporosis or other conditions that HRT can help manage. Advanced diagnostic tools like Coronary CT Angiograms (CCTA) can provide valuable insights into a patient’s heart health, helping to stratify risk and guide decisions about HRT.
The relationship between HRT and brain health, particularly concerning dementia, is another area of ongoing debate. Some studies, like an 18-year follow-up of the WHI, showed a significant reduction in death from dementia among women using oral estradiol alone. However, other studies, such as the 2019 Finnish cohort study, indicated a subtle increased risk of dementia with HRT exposure.
A 2023 meta-analysis provided more clarity, suggesting that starting HRT within 10 years of menopause appears to protect against dementia, especially with estrogen therapy. The benefits are less clear if HRT is started later, but continued use of estrogen after age 65 was associated with protection against dementia in a recent study.
Estrogen’s neuroprotective effects are thought to be related to its anti-inflammatory properties, its role in vascular health, and its impact on amyloid metabolism and neuroplasticity. While the evidence isn’t definitive, it raises important questions about why we treat women who undergo early menopause differently from those who reach menopause at a typical age. Shouldn’t we consider similar protective measures for brain health in all women?
One of the most compelling reasons to reconsider HRT in older women is its potential impact on longevity. A recent study on women continuing HRT after age 65 showed significant reductions in mortality, breast cancer, lung cancer, colon cancer, and heart attacks. These benefits were more pronounced with estrogen replacement, while combined therapy did not fare as well, likely due to the risks associated with progestins.
This evidence challenges the idea that HRT should automatically be discontinued after a certain age. From a longevity perspective, the assumption that continued hormone replacement at low or physiologic levels is dangerous lacks substantial evidence. Instead, we should focus on proving harm rather than assuming it exists.
Many doctors are hesitant to recommend HRT after 10 years or past age 65, but this perspective is increasingly being challenged by new research. If you’ve been told not to start or to stop HRT due to concerns about heart or brain health, even when continuing HRT could be in your best interest, you may want to get a second opinion!
HRT should be considered as part of a holistic strategy for aging, focusing on maintaining heart and brain health while also addressing other concerns like bone density and overall longevity. The decision to start or continue HRT should be based on individual risk factors and health status, not just age. By staying informed and discussing these issues with a knowledgeable healthcare provider, you can make decisions that support your long-term health and well-being.
As we continue to explore the nuances of HRT, it’s essential to approach it through the lens of HealthSpan—living better for longer. Whether it’s starting HRT in your 50s or continuing it into your 70s and beyond, the goal should always be to maximize your quality of life and protect your health for the years ahead.
.jpg)
Access to proper care and personalized hormone replacement therapy (HRT) is crucial for women to fully benefit from its potential in optimizing health and relieving menopausal symptoms.
.svg){kind=icon}
.jpg)
Optimizing hormone replacement therapy (HRT) requires personalized care, regular monitoring, and the right combination of hormones, doses, and delivery methods to achieve the best health outcomes.
.jpg)
Rhythmic hormone replacement therapy, which mimics natural hormonal cycles, may offer greater health benefits than traditional static dosing, potentially improving outcomes for bone, breast, and cardiovascular health in postmenopausal women.
